Children's Health Defense The two University of Pennsylvania scientists are co-inventors on patents for using mRNA technology as a vaccine platform. One of the scientists also receives money for consulting services from several pharmaceutical companies, including Pfizer and Merck.
Federally funded researchers have developed an experimental mRNA H5N1 bird flu vaccine that they said is “highly effective” in preventing severe illness and death in infected lab animals.
According to a University of Pennsylvania press release, the vaccine “could potentially help manage the outbreak of the H5N1 virus currently circulating in birds and cattle in the United States, and prevent human infections with the virus.”
The news comes as the U.S. and European nations consider vaccinating workers deemed as at risk for contracting bird flu.
The researchers — who on May 23 published their results in Nature Communications — reported their mRNA lipid nanoparticle vaccine elicited “strong” T cell and antibody responses in female mice infected with H5N1.
They also said their vaccine produced an immune response in male ferrets and prevented death.
Read Full Article Here…(childrenshealthdefense.org)
Home | Caravan to Midnight (zutalk.com)
Live Stream + Chat (zutalk.com)
Be First to Comment